Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPOD
5576
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $1.87M | ﹤0.01% |
187,931
+102,511
| +120% | +$1.03M |
|
5577
CALL
MarineMax
HZO
$1.15B
| $1.86M | ﹤0.01% |
51,600
-500
| -1% | -$20.1K |
|
5578
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.21B
| $1.86M | ﹤0.01% |
38,615
-231,420
| -86% | -$11.4M |
|
|
MTTR
5579
CALL
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.86M | ﹤0.01% |
509,000
-21,900
| -4% | -$120K |
|
5580
CALL
Vipshop
VIPS
$6.73B
| $1.86M | ﹤0.01% |
188,300
-87,700
| -32% | -$772K |
|
5581
CALL
Sensient Technologies
SXT
$5.66B
| $1.86M | ﹤0.01% |
23,100
+14,500
| +169% | +$1.2M |
|
|
DCT
5582
CALL
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $1.86M | ﹤0.01% |
125,200
+29,200
| +30% | +$513K |
|
5583
CALL
Costamare
CMRE
$1.82B
| $1.86M | ﹤0.01% |
153,400
-33,900
| -18% | -$471K |
|
|
TRTX
5584
TPG RE Finance Trust
TRTX
$609M
| $1.86M | ﹤0.01% |
205,925
-103,369
| -33% | -$1.08M |
|
|
HLTH
5585
CALL
DELISTED
Cue Health Inc. Common Stock
HLTH
| $1.85M | ﹤0.01% |
579,600
+372,300
| +180% | +$2.02M |
|
|
SNV
5586
PUT
DELISTED
Synovus
SNV
| $1.85M | ﹤0.01% |
51,400
-4,900
| -9% | -$203K |
|
5587
BJ's Restaurants
BJRI
$1.41B
| $1.85M | ﹤0.01% |
85,359
-46,562
| -35% | -$1.2M |
|
5588
CALL
Design Therapeutics
DSGN
$922M
| $1.85M | ﹤0.01% |
+132,200
| New | +$1.79M |
|
|
AMRN
5589
Amarin Corp
AMRN
$297M
| $1.85M | ﹤0.01% |
62,084
-58,207
| -48% | -$2.51M |
|
5590
First Trust Cloud Computing ETF
SKYY
$3.32B
| $1.85M | ﹤0.01% |
+28,077
| New | +$2.07M |
|
|
AVAN
5591
CALL
DELISTED
Avanti Acquisition Corp.
AVAN
| $1.85M | ﹤0.01% |
186,700
+158,900
| +572% | +$1.57M |
|
5592
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.26B
| $1.85M | ﹤0.01% |
21,053
+6,681
| +46% | +$645K |
|
5593
NextCure
NXTC
$35.7M
| $1.85M | ﹤0.01% |
32,781
+282
| +0.9% | +$14.7K |
|
5594
CALL
Cytokinetics
CYTK
$10.4B
| $1.85M | ﹤0.01% |
47,000
+29,800
| +173% | +$1.2M |
|
5595
PUT
Hilton Grand Vacations
HGV
$3.52B
| $1.85M | ﹤0.01% |
51,700
+43,300
| +515% | +$1.93M |
|
5596
PUT
Woodside Energy
WDS
$44.9B
| $1.85M | ﹤0.01% |
+85,688
| New | +$1.94M |
|
|
CUTR
5597
DELISTED
Cutera, Inc.
CUTR
| $1.85M | ﹤0.01% |
49,227
+8,134
| +20% | +$429K |
|
5598
CALL
Amplify Alternative Harvest ETF
MJ
$113M
| $1.84M | ﹤0.01% |
26,492
-9,033
| -25% | -$836K |
|
5599
Karyopharm Therapeutics
KPTI
$43.3M
| $1.84M | ﹤0.01% |
27,223
-29,745
| -52% | -$2.73M |
|
5600
CALL
Customers Bancorp
CUBI
$2.79B
| $1.84M | ﹤0.01% |
54,300
-10,400
| -16% | -$423K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.